TTD vs. MRNA
TTD (The Trade Desk, Inc.) and MRNA (Moderna, Inc.) are both stocks. TTD operates in Software - Application (Technology), while MRNA operates in Biotechnology (Healthcare). Over the past 5 years, TTD returned -20.31%/yr vs -25.59%/yr for MRNA. At a 0.25 correlation, their price movements are largely independent.
Performance
TTD vs. MRNA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TTD achieves a -49.21% return, which is significantly lower than MRNA's 69.24% return.
TTD
- 1D
- 2.01%
- 1M
- -8.84%
- YTD
- -49.21%
- 6M
- -47.39%
- 1Y
- -71.63%
- 3Y*
- -37.11%
- 5Y*
- -20.31%
- 10Y*
- —
MRNA
- 1D
- 0.54%
- 1M
- 1.77%
- YTD
- 69.24%
- 6M
- 69.42%
- 1Y
- 87.14%
- 3Y*
- -26.94%
- 5Y*
- -25.59%
- 10Y*
- —
TTD vs. MRNA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
TTD The Trade Desk, Inc. | -49.21% | -67.70% | 63.33% | 60.52% | -51.08% | 14.41% | 208.34% | 123.83% | -18.19% |
MRNA Moderna, Inc. | 69.24% | -29.08% | -58.19% | -44.63% | -29.28% | 143.11% | 434.10% | 28.09% | -30.59% |
Correlation
The correlation between TTD and MRNA is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.17 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.20 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.29 |
Correlation (All Time) Calculated using the full available price history since Dec 7, 2018 | 0.25 |
The correlation between TTD and MRNA shifts across timeframes, from 0.17 (1 year) to 0.29 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
TTD:
$9.19B
MRNA:
$19.71B
TTD:
$0.89
MRNA:
-$8.16
TTD:
3.16
MRNA:
8.78
TTD:
3.75
MRNA:
2.66
TTD:
$2.97B
MRNA:
$2.23B
TTD:
$2.31B
MRNA:
-$309.00M
TTD:
$725.01M
MRNA:
-$3.02B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TTD vs. MRNA — Risk / Return Rank
TTD
MRNA
TTD vs. MRNA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for The Trade Desk, Inc. (TTD) and Moderna, Inc. (MRNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TTD | MRNA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.42 | ||
| Sortino ratioReturn per unit of downside risk | -4.10 | ||
| Omega ratioGain probability vs. loss probability | 0.71 | 1.24 | -0.53 |
| Calmar ratioReturn relative to maximum drawdown | -0.92 | 2.34 | -3.26 |
| Martin ratioReturn relative to average drawdown | -1.28 | 4.59 | -5.86 |
Loading charts...
Drawdowns
TTD vs. MRNA - Drawdown Comparison
The maximum TTD drawdown since its inception was -86.45%, smaller than the maximum MRNA drawdown of -95.38%. Use the drawdown chart below to compare losses from any high point for TTD and MRNA.
Loading charts...
Drawdown Indicators
| TTD | MRNA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -86.45% | -95.38% | +8.93% |
Max Drawdown (1Y)Largest decline over 1 year | -78.94% | -35.51% | -43.43% |
Max Drawdown (3Y)Largest decline over 3 years | -86.45% | -86.58% | +0.13% |
Max Drawdown (5Y)Largest decline over 5 years | -86.45% | -95.38% | +8.93% |
Current DrawdownCurrent decline from peak | -86.18% | -89.70% | +3.52% |
Average DrawdownAverage peak-to-trough decline | -27.27% | -57.06% | +29.79% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 56.84% | 18.06% | +38.78% |
Volatility
TTD vs. MRNA - Volatility Comparison
The Trade Desk, Inc. (TTD) has a higher volatility of 18.89% compared to Moderna, Inc. (MRNA) at 17.56%. This indicates that TTD's price experiences larger fluctuations and is considered to be riskier than MRNA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TTD | MRNA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 18.89% | 17.56% | +1.33% |
Volatility (6M)Calculated over the trailing 6-month period | 41.21% | 48.82% | -7.61% |
Volatility (1Y)Calculated over the trailing 1-year period | 64.24% | 64.75% | -0.51% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 67.34% | 66.49% | +0.85% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 68.43% | 72.15% | -3.72% |
Dividends
TTD vs. MRNA - Dividend Comparison
Neither TTD nor MRNA has paid dividends to shareholders.
Financials
TTD vs. MRNA - Financials Comparison
This section allows you to compare key financial metrics between The Trade Desk, Inc. and Moderna, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
TTD and MRNA have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
TTD has higher volatility (18.89%) compared to MRNA (17.56%). In terms of maximum drawdown, TTD dropped -86.45% vs MRNA's -95.38%.
MRNA currently has the higher Sharpe Ratio (1.28 vs -1.13), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TTD and MRNA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer